Pre-market · Oct 8, 7:40 am ET · After hours $8.50 0.00%
Open$8.83
Prev close$8.72
Day range$8.35 – $8.83
Volume173.7K
Market cap$523.50M
P/E (TTM)–
Dividend yield–
OCS Stock News
Headlines matching Oculis or the OCS ticker, most recent first.
Top-performing Hong Kong stocks this week | Lightelligence shares rose more than 21% for the week, with its Scale-up OCS becoming a core growth engine; the company was included in the Stock Connect program this month. Maifeishi gained nearly 21%, upgradinPositiveMarket news · 5 Sep 2026 · Direct mention
Stifel Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $40Market news · 28 Sep 2026 · Direct mention
Dongtu Technology (300353.SZ): The industrial network communications business segment does not involve OCS optical circuit switching products.Gelonghui Finance · 23 Sep 2026 · Direct mention
H.C. Wainwright Maintains Oculis(OCS.US) With Buy Rating, Raises Target Price to $39PositiveMarket news · 18 Sep 2026 · Direct mention
LifeSci Capital Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $41Market news · 8 Aug 2026 · Direct mention
Needham Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $38Market news · 8 Aug 2026 · Direct mention
LifeSci Capital Maintains Oculis(OCS.US) With Buy Rating, Cuts Target Price to $41NegativeMarket news · 7 Aug 2026 · Direct mention
Guggenheim Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $45Market news · 7 Aug 2026 · Direct mention
LifeSci Capital Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $45Market news · 6 Aug 2026 · Direct mention
TransMedics (TMDX): Buy Rating Backed by Accelerating U.S. Organ Transplant Volumes and Expanding OCS UtilizationTipRanks · 3 Aug 2026 · Direct mention
H.C. Wainwright Maintains Oculis(OCS.US) With Buy Rating, Maintains Target Price $26Market news · 25 Aug 2026 · Direct mention
J.P. Morgan Maintains Oculis(OCS.US) With Buy Rating, Cuts Target Price to $20NegativeMarket news · 14 Aug 2026 · Direct mention
J.P. Morgan Gives a Buy Rating to Oculis Holding (OCS)TipRanks · 14 Aug 2026 · Direct mention
Analysts Have Conflicting Sentiments on These Healthcare Companies: Oculis Holding (OCS), Stevanato Group (STVN) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)TipRanks · 10 Aug 2026 · Direct mention
J.P. Morgan Maintains Oculis(OCS.US) With Buy Rating, Announces Target Price $23Market news · 3 Jun 2026 · Direct mention
Discussion
No comments yet — be the first to weigh in on OCS.
No comments yet — be the first to weigh in on OCS.